where C in and C out were the constant inlet and steady-state outlet concentrations of the NO donors (SNP or ISDN), respectively. The latter (C out ) was the average concentration of the last six outlet perfusate samples for SNP and last four outlet samples for ISDN. The hepatic (CL h ), intrinsic (CL int ), and biliary (CL bile ) clearances of SNP or ISDN were then calculated using the following equations:
CL bile = A bile AUC perfusate (4) where A bile is the amount of unchanged drug eliminated in the bile during 60 min of perfusion, and AUC perfusate is the AUC of the NO donor in the outlet perfusate from 0 to 60 min of perfusion.
Microsomes, Total CYP and Cytochrome b 5 Content, and Cytochrome C Reductase
Activity. Microsomes were prepared at the end of 1-h perfusion using standard ultracentrifugation methods (Lake, 1987) and stored at -80 o C. Cytochrome b 5 and Carbon monoxide-bound CYP contents were determined by the method of Omura and Sato (Lake, 1987) . Total protein content was measured based on Bradford assay using bovine serum albumin as protein standard. Cytochrome c reductase activity was measured using a kinetic assay as described before (Guengerich, 1994) .
Analysis of Heme, Thiols, and Nitrotyrosine. Total heme was measured by subjecting the microsomes to the pyridine-hemochromogen method (Lake, 1987) . Briefly, after the addition of 0.5 ml of 0.5 M NaOH and 0.5 ml of pyridine to 1.5 ml of microsomal suspensions (~1.5 mg protein per ml), the test sample was reduced with sodium dithionite and its spectrum analyzed against a fully-oxidized (potassium ferricyanide) reference. Free heme was measured by the same method after ultrafiltration of microsomal suspensions using Microcon YM-10 filters with 10 kD MW cut-off (Millipore Corporation, Bedford, MA). For determination of thiols, the Ellman's reagent was used as described in detail previously (Minamiyama et al., 1997) .
Nitrotyrosine levels in the microsomes (~25 mg protein per ml or ~20 µM of CYP) were quantitated using a commercially-available ELISA kit (OxisResearch, Portland, OR) according to the manufacturer's specifications. The detection limit of the assay is 2 nM, corresponding to 0.1 pmol of nitrotyrosine per nmol of CYP.
Analysis of CYP Isoform Activities and Protein Contents. Activities of CYP3A2 and
2C11 were analyzed using formation of 6β-and 16α-hydroxytestosterone, respectively, from testosterone, based on modifications made to a previously published method (Purdon and Lehman-McKeeman, 1997) . Briefly, a reaction mixture of 1 ml containing 0.2 mg of microsomal protein, MgCl 2 (3 mM), isocitric acid (0.4 M), isocitrate dehydrogenase (77.7 U/ ml), EDTA (1 mM), and NADP+ (1 mM) in phosphate buffer (pH 7.4) was incubated at 37ºC for 10 min. The reaction was initiated by the addition of testosterone (150 µM). The remainder of the procedure was similar to the published method (Purdon and Lehman-McKeeman, 1997).
The activity of CYP2E1 was assessed based on the modifications made to a previously established method (Jayyosi et al., 1995) that uses chlorzoxazone as a substrate. In brief, a 250-µl reaction mixture containing chlorzoxazone (250 µM), NADPH (1 mM), and MgCl 2 (5 mM) in
Tris-HCl buffer pH 7.4 was incubated at 37ºC for 20 min. The reaction was initiated by the addition of 0.1 mg of microsomal protein. After termination of the reaction with 5 µl of 70% perchloric acid, 100 µl of 10 µg/ml umbelliferone (internal standard) was added. The contents were vortexed and centrifuged before injection onto the HPLC system.
Dextromethorphan hydroxylation was employed to assess the activity of CYP2D1. The method used for the analysis was based on modifications made to a previously reported HPLC method (Yu and Haining, 2001) . Briefly, dextromethorphan (10 µM) was added to 100 µl of the reaction mixture containing 50 µg of microsomal protein, MgCl 2 (5 mM), isocitric acid (5 mM), isocitrate dehydrogenase (77.7 U/ml), and NADP+ (1 mM), and the mixture was incubated at 37ºC for 20 min. After the termination of the reaction with 5 µl of 70% perchloric acid, the reaction mixture was vortexed, centrifuged, and injected onto the HPLC system.
The activities of CYP2B1/2 and CYP1A1/2 were assessed by formation of resorufin from benzyloxy-and ethoxy-resorufin as substrates, respectively (Burke et al., 1985; Rutten et al., 1992) . The concentrations of resorufin were measured fluorometrically.
Protein contents of CYP3A2, 2E1, and 2C11 were measured according to an ELISA method reported earlier (Snawder and Lipscomb, 2000) . Microsomal proteins used were 0.15 µg for CYP2E1 and CYP2C11 and 1 µg for CYP3A2 analysis. Isoform protein values were expressed as pmol per milligram protein.
Concentration (or Amount)-Effect relationships.
The CYP450 inhibitory effects of SNP or ISDN (I) and the concentrations (or amounts) of the drugs or the generated NO x (C) were fitted to the sigmoidal I MAX model using the following equation:
where I MAX , IC 50 , and γ are the maximum inhibitory effect, the concentration (or amount)
producing half of I MAX , and the steepness factor, respectively. The model parameters were estimated using the nonlinear regression program WinNonlin (Pharsight Co.; Mountain View, CA).
Statistical Analysis. All the statistical comparisons were conducted using ANOVA with subsequent Fisher's test. The linearity of relationships between two parameters (e.g., NO x concentrations versus NO donor concentrations) was tested using an F test based on the comparison of sum of squares due to the deviation of the observed values from the regression line and those due to the variability within each treatment group (Bolton, 1984) . All tests were conducted using a significance level of 0.05. Data are presented as mean ± S.E. Fig. 1, bottom) . However, similar to SNP, the outlet concentrations of ISDN were proportional to its inlet concentrations (P > 0.05 for comparison of dose-corrected AUCs).
Results

SNP and ISDN
The hepatic disposition parameters of SNP and ISDN are presented in higher than that in livers perfused with 50, 100, or 200 µM of SNP ( Table 1) . As for bile flow rates, the values in the livers treated with either drug were higher (P < 0.05) than those in the untreated livers (Table 1 ).
The concentrations of NO x in the outlet perfusate at the end of perfusion (60 min) and the total (0-60 min) amounts of NO x recovered in the bile are presented in Fig However, a 10-fold increase in the inlet concentrations of SNP to 500 µM caused only a 2-fold increase in the NO x levels in the perfusate (Fig. 2, top) . Similarly, a 5-fold increase in the inlet concentrations of ISDN resulted in a less than proportional (3 fold) increase in the NO x concentrations ( Fig. 2, top) . Nevertheless, at inlet concentrations of 200 and 500 µM, ISDN produced higher (P < 0.05) NO x levels in the outlet perfusate than did SNP (Fig. 2, top) . In contrast to the NO x concentrations in the outlet perfusate, the amount of NO x in bile increased linearly with an increase in the inlet concentrations of SNP or ISDN (Fig. 2 , bottom).
Additionally, significantly (P < 0.01) smaller amounts of NO x were found in the bile after ISDN than SNP (Fig. 2, bottom) .
The concentrations of ALT and AST in the outlet perfusate samples at the beginning of perfusion were low and remained low (< 10 U/l) during the entire period of perfusion (60 min). The levels of microsomal heme and thiols are depicted in Fig. 4 . At concentrations of 100, 200, and 500 µM, SNP caused, respectively, 18% (P < 0.01), 40% (P < 0.001), and 51% (P < 0.001) reductions in the total heme content of microsomes (Fig. 4, top) . For ISDN, the reductions (~50%) were significant (P < 0.001) only at 200 and 500 µM concentrations. No free heme was detected in our microsomal preparations obtained from either control or treated livers.
General Microsomal
As for free (non-nitrosylated thiols), significant (P < 0.05), but moderate (17-24%), reductions were observed only at high concentrations (200 and/or 500 µM) of SNP or ISDN (Fig. 4, bottom).
The levels of nitrotyrosine in our microsomal preparations were below the detection limit of the ELISA method, which was 2 nM or 0.1 pmol nitrotyrosine per nmol of CYP.
CYP3A2, 2C11, and 2E1 Activities and Protein Levels. Profiles of CYP3A2 activities and protein levels are presented in Fig. 5 . The activity of CYP3A2 in livers perfused with SNP significantly decreased (P < 0.05) in a dose-dependent manner (Fig. 5, top) . The degrees of reduction in the activity of CYP3A2 were 34%, 47%, 69%, and 75% for 50, 100, 200, and 500 µM concentrations of SNP, respectively. Additionally, perfusion of livers with ISDN 200 or ISDN 500 also resulted in a significant decrease (~47% for both concentrations) in the CYP3A2 activity (P < 0.01) (Fig. 5, top) . The inhibitory effect of ISDN appeared to be less than that observed after similar concentrations of SNP (Fig 5, top) . A substantial interindividual variability was observed in the protein levels of CYP3A2, measured by the ELISA method (Fig.   5 , bottom). However, unlike the activities, protein levels remained unaltered in all the treatment groups and were comparable to the control livers (Fig. 5, bottom) .
Profiles of CYP2C11 activities as well as protein levels are presented in Fig. 6 . Similar to CYP3A2, the activity of CYP2C11 was inhibited by SNP in a dose-dependent manner. However, the inhibitory effect of SNP 50 was not significant (Fig. 6 ). The percentages of reduction in the CYP2C11 activities were 40, 82, and 80, for SNP inlet concentrations of 100, 200, and 500 µM, respectively (P < 0.05). Additionally, CYP2C11 activity was significantly reduced in ISDN 200
and ISDN 500 groups by 58% and 76%, respectively (Fig. 6, top) . As for protein levels, they were not significantly affected by all the treatments except for the 500 µM of SNP or ISDN, which resulted in 43% or 66% reductions, respectively (Fig. 6, bottom) .
Perfusion of livers with SNP also caused a dose-dependent decrease in the activity of CYP2E1 (Fig. 7, top) ; percentages of reduction were 27, 53, 76, and 74, for SNP concentrations of 50, 100, 200, and 500 µM, respectively (P < 0.05). Although ISDN also significantly reduced the activity of 2E1, its effects were significantly less than that of SNP at similar concentrations (Fig. 7, top) . The protein levels of CYP2E1 remained unchanged in five out of the six treated groups (Fig. 7, bottom) .
CYP1A1/2, 2B1/2, and 2D1 Activities. The microsomes obtained from livers perfused with different concentrations of SNP or ISDN were also analyzed for the dealkylation activities of CYP1A1/2, 2B1/2, and 2D1 (Fig. 8) . The extent and pattern of inhibitory effects of NO donors on the activity profiles of CYP1A1/2 (Fig. 8, top ) and CYP2B1/2 (Fig. 8 , middle) were similar to those seen for CYP3A2, 2C11, and 2E1. However, unlike the other studied CYPs, the influence of NO donors on the activity of CYP2D1 was minimal, if any (Fig. 8, bottom) .
Concentration-Inhibitory Effect Relationships.
The concentration-inhibitory effect relationships are shown in Fig. 9 for CYP3A2 activity versus the concentrations of SNP in the inlet perfusate, NO x amounts recovered in bile, and NO x concentrations in the outlet perfusate.
Similar profiles were observed for other isoenzymes affected by NO donors (Figures not shown) .
Additionally, the pharmacodynamic parameters estimated from these relationships are presented
in Table 2 for all the affected enzymes. For each CYP isozyme, the estimated I MAX values obtained from three different regression methods were similar ( Fig. 9 and Table 2 ). However, as expected the IC 50 and γ values were dependent on the type of dependent variable (concentrations of SNP in the perfusate or concentrations or amounts of NO x in the perfusate or bile) ( Table 2 ).
The maximum inhibitory effects of SNP treatment on the enzyme activity were relatively similar for all the studied isozymes and ranged from 63% (1A1/2) to 85% (2C11) ( were very close for all the isozymes (Table 2) .
Because of a small number of data points (three concentrations), the concentration-effect relationships were not constructed for ISDN.
Discussion
Hepatic Disposition of NO Donors. Although the in vivo disposition of SNP and ISDN has been reported previously in both humans (Schulz, 1984; Fung, 1985) and rats (Kreye and Reske, 1982; Morrison and Fung, 1984) , our study is the first to show the detailed hepatic disposition, including biliary excretion, of SNP or ISDN in an IPRL model ( Fig. 1 and Table 1 ).
In addition to metabolism by liver microsomes (Rao et al., 1991; Minamiyama et al., 2001) , both ISDN and SNP undergo metabolism to generate NO and other metabolites in vascular smooth muscle (Kreye and Reske, 1982; Fung et al., 1984) . Therefore, the E and CL h values presented here (Table 1) represent metabolism of SNP and ISDN by both hepatic vasculature and the hepatocytes.
The linearity in the hepatic disposition of SNP within the concentration range of 50-500 µM ( Fig. 1 and Table 1 ) is consistent with the drug's main metabolic pathway; in hepatocytes, SNP is reduced by CYP reductase (Rao et al., 1991) , a pathway that remained unchanged after treatment with NO donors (Fig. 3, bottom) . Similarly, despite a significant NO-dependent reduction in the catalytic activities of microsomal 1A1/2 (Fig. 8, top) and 2E1 (Fig. 7, top (Morrison and Fung, 1984) . Therefore, approximately two thirds of the systemic clearance of ISDN in rats is indeed due to extrahepatic metabolic pathways.
Although in small amounts, the presence of intact SNP or ISDN in bile (Table 1) indicates that hepatocytes have indeed been exposed to intact NO donors which could generate NO within the hepatocytes. The presence of NO x in the bile (Fig. 2) further supports this argument.
Effects of NO Donors on CYP Activity and Protein. Our observations clearly show
that NO donors rapidly and concentration-dependently decrease the total CYP content (Fig. 3) and activities (Figs. 5-8) in an IPRL model. However, the protein levels of the affected isoenzymes are largely unaltered (Figs. 5-7) . We measured the total CYP content using the standard CO differential spectra analysis, which requires the presence of intact protein-bound heme. Theoretically, the observed decrease in the total CYP content may be due to binding of NO to the heme prosthetic groups (Wink et al., 1993; Minamiyama et al., 1997) and/or loss of enzyme-bound heme (Kim et al., 1995) . However, because the microsomal CYP-NO complexes dissociate rapidly (Minamiyama et al., 1997 ) (e.g., during microsomal preparation), the reduction in CYP content, observed in our IPRL studies, is due mostly to the loss and degradation of enzyme-bound heme (Kim et al., 1995) . The observed reductions in total heme contents of microsomal preparations in the livers treated with NO donors (Fig. 4, top) are in agreement with this postulate. While, the loss of heme is expected to reduce the CYP catalytic activities, it is unlikely to affect the ELISA-measured isoenzyme protein levels.
The reductions in CYP content alone (Fig. 3, top) cannot fully explain the changes in the activities of various isoforms observed after NO exposure . Therefore, other mechanisms must be in place. One such mechanism is the interaction of NO with sulfhydryl groups of cysteine amino acid residues in various CYPs, forming reversible S-nitrosothiols which have relatively long half lives (Minamiyama et al., 1997) . If the cysteine residues are critical for the interaction of ligand with the isoenzyme, formation of S-nitrosothiols could result in a reduced activity. In fact, the reaction of NO with cysteinyl groups of 3A2 and 2C11 were held responsible for the reductions in the 16α-and 6β-hydroxylation of testosterone by microsomes that were directly exposed to an NO donor (Minamiyama et al., 1997) . In our studies, NO donors caused a moderate reduction in the free sulfhydryl groups only at high concentrations (Fig. 4, bottom) . However, it should be noted that the reaction of NO with one or more critical cysteine groups of a CYP isoform may have a dramatic effect on its activity without a substantial effect on the overall number of free thiols. Therefore, the % reduction in thiols may not be compared to the % reduction in the activity of the individual CYP isoforms.
Another potential mechanism for the NO-induced inhibition of CYP activity is an irreversible nitration of tyrosine residues, which are positioned at the active site of the enzyme or are involved in electron transfer, by the NO-derived peroxynitrite (Roberts et al., 1998) . For example, peroxynitrite-mediated nitration of tyrosine residues of CYP2B1 significantly reduced its catalytic activity (Roberts et al., 1998) , an effect which was abolished by mutation of tyrosine 190 to alanine (Lin et al., 2003) . However, in agreement with a microsomal study (Minamiyama et al., 1997) , nitrotyrosine was not detected in our model.
The CYP isoenzyme-specific inhibitory responses to NO (Figs. 5-8) may be explained by the reductions in thiol (Fig. 4) and/or cytochrome b 5 (Fig. 3) contents. Various CYP isoenzymes contain 4-9 free cysteinyl residues (Minamiyama et al., 1997) . Therefore, depending on the number of free cysteinyl groups and their position relative to the active site, the response of different isoenzymes to the presence of NO may be different. Additionally, because cytochrome b 5 has isoenzyme-specific stimulatory effects on the CYP activities (Yamazaki et al., 2002) , the NO-induced reduction in the cytochrome b 5 contents (Fig. 3, middle ) may affect the activities of different isoforms to a different extent.
In contrast to significant reductions in catalytic activities observed for all the other studied isoenzymes (Figs. 5-8 ), the NO-induced changes in the activity of CYP2D1 were minimal (Fig. 8, bottom) . This observation suggests that NO does not interact with CYP2D1 at critical sites. Indeed, recent reports (Paine et al., 2003) have clearly shown that negativelycharged carboxylate-containing amino acids, such as Aspartate-301 and Glutamate-216, are critical for the interaction of 2D6 with basic nitrogen-containing ligands. Therefore, the lack of the effect of NO donors on 2D1 may be due to the lack of cysteine and/or tyrosine residues at the critical site(s) of the isozyme. Further, several in vitro studies (Yamazaki et al., 2002) have shown that, in contrast to most other CYP isoforms, the activity of CYP2D6 is not stimulated by cytochrome b 5 . Hence, the NO-induced reduction in cytochrome b 5 content (Fig. 3, middle) is not expected to affect the activity of this isoform.
In addition to the alterations in the catalytic activities of CYP isoenzymes, NO could potentially decrease CYP mRNA and apoprotein levels (Stadler et al., 1994; Khatsenko and Kikkawa, 1997) . However, the protein levels of CYP3A2 (Fig. 5) , 2C11 (Fig. 6) , and 2E1 (Fig.   7) , which constitute majority of total CYP in male rats, were not substantially altered in our studies. This is most likely due to our short experimental time (1 h).
Concentration (Amount)-Effect Relationships.
Because of its linear hepatic disposition (Table 1) , the inlet concentrations of SNP are expected to be directly related to the concentrations of SNP and generated NO in hepatocytes. Similarly, the biliary amounts of NO x reflect the exposure of the hepatocytes to SNP and NO. Therefore, it is not surprising that the inhibitory effect-concentrations (or amount) profiles were qualitatively similar when SNP inlet concentrations or biliary NO x amounts were used as the independent variable (Fig. 9) .
Conversely, the NO x concentrations in the outlet perfusate may not be a true representation of hepatocyte exposure to NO because NO may be generated from SNP in the liver vasculature (Kreye and Reske, 1982) . Therefore, the inlet concentrations of NO donors or the biliary amounts of NO x are more appropriate predictors of the CYP inhibitory effects of NO donors than are the perfusate NO x levels. (Wink et al., 1993) It should be noted that the Griess reagent used in our studies measures NO metabolites (NO x ) as an indirect measure of NO exposure. However, the metabolism of ISDN may produce NO x independent of the formation of NO (Fung et al., 1984) . Therefore, the NO x levels after ISDN administration may be an overestimation of the liver exposure to NO. Further, NO species other than free radical (e.g., nitroxyl or nitrosonium intermediates), which may be present after JPET #65557 22 SNP administration (Rao et al., 1991) , may also react with CYPs. Consequently, the effects of exogenously administered SNP on CYPs may not be completely similar to those of NO derived in vivo from NO synthase.
Conclusions
In conclusion, our findings indicate that NO decreases the CYP-mediated drug metabolism in an isolated perfused rat liver model. The NO effect on drug metabolism is direct,
rapid ( 
